Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A2  David Mauchley, MD, Xianzhong Meng, MD, PhD, Thomas.

Slides:



Advertisements
Similar presentations
Expression of LKB1 tumor suppressor in non–small cell lung cancer determines sensitivity to 2-deoxyglucose  Landon J. Inge, PhD, Keith D. Coon, PhD, Michael.
Advertisements

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma  Christopher W. Seder, MD, Wibisono.
Stephen R. Broderick, MD, MPHS 
Inhibition of hypoxia-induced cyclooxygenase-2 by Korean Red Ginseng is dependent on peroxisome proliferator-activated receptor gamma  Heewon Song, Young.
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
Heat shock protein 27: Induction by gastroduodenal reflux in vivo and augmentation of human esophageal mucosal cell growth in vitro  David Mauchley, MD,
Induction by left ventricular overload and left ventricular failure of the human Jumonji gene (JARID2) encoding a protein that regulates transcription.
Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer.
The role of Dickkopf-3 overexpression in esophageal adenocarcinoma
Prevention of lung ischemia–reperfusion injury by short hairpin RNA–mediated caspase- 3 gene silencing  Yong-Xing Zhang, MD, Hong Fan, PhD, Yu Shi, MD,
PFKFB3, a Direct Target of p63, Is Required for Proliferation and Inhibits Differentiation in Epidermal Keratinocytes  Robert B. Hamanaka, Gökhan M. Mutlu 
Wei Zhou, MD, Hong Chai, MD, PhD, Andy Courson, BS, Peter H
Twist-related protein 1 negatively regulated osteoblastic transdifferentiation of human aortic valve interstitial cells by directly inhibiting runt-related.
Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo  Jessica A. Yu, MD, David Mauchley, MD, Howard Li, MD, Xianzhong.
INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma  Christopher W. Seder, MD, Wibisono.
Dimethyl celecoxib as a novel non–cyclooxygenase 2 therapy in the treatment of non– small cell lung cancer  Leah M. Backhus, MD, Nicos A. Petasis, PhD,
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma  Mor-Li Hartman, PhD, John Matthew Esposito, BA, Beow Yong.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting with cardiopulmonary bypass  Michael P. Robich, MD,
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma  Jun Wang, MD, PhD, Zhi Li, MD, PhD,
Expression of LKB1 tumor suppressor in non–small cell lung cancer determines sensitivity to 2-deoxyglucose  Landon J. Inge, PhD, Keith D. Coon, PhD, Michael.
Brahma-related gene 1 inhibits proliferation and migration of human aortic smooth muscle cells by directly up-regulating Ras-related associated with diabetes.
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Secretory phospholipase A2 is required to produce histologic changes associated with gastroduodenal reflux in a murine model  Ashok Babu, MD, Xianzhong.
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma
A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: Modulation of cell migration and proliferation  Thomas S. Monahan,
Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro  Min You, PhD, Javier Varona-Santos,
Activated Leukocyte Cell-Adhesion Molecule (ALCAM) Promotes Malignant Phenotypes of Malignant Mesothelioma  Futoshi Ishiguro, MD, Hideki Murakami, MD,
Chandra Goparaju, PhD, Jessica S
Combined proteasome and histone deacetylase inhibition attenuates epithelial– mesenchymal transition through E-cadherin in esophageal cancer cells  Matthew.
Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects  Yasuaki Kishimoto, MD, Taichi Kato, MD, PhD, Mikako.
Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: Role of Smad1 and extracellular signal-regulated.
Lipopolysaccharide Stimulation of Human Aortic Valve Interstitial Cells Activates Inflammation and Osteogenesis  Ashok N. Babu, MD, Xianzhong Meng, MD,
Patrick D. Kohtz, MD, Alison L. Halpern, MD, Mohamed A
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
Miral R. Sadaria, MD, Amy E. Reppert, MD, Jessica A
Lung cancer cell invasion and expression of intercellular adhesion molecule-1 (ICAM-1) are attenuated by secretory phospholipase A2 inhibition  Jessica.
Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with.
Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 
Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines:
The lord of the rings  Antonio Miceli, MD, PhD 
The Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes  Wei Zhao, Joseph Mazar, Bongyong Lee, Junko Sawada, Jian-Liang.
Erythropoietin activates the phosporylated cAMP [adenosine 3′5′ cyclic monophosphate] response element-binding protein pathway and attenuates delayed.
Platelet-derived growth factor is a cofactor in the induction of 1α(I) procollagen expression by transforming growth factor β1 in smooth muscle cells 
Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non–small cell lung cancer 
Alternative splicing in heart surgery: Lost in translation?
Secretory Phospholipase A2 Inhibition Attenuates Intercellular Adhesion Molecule-1 Expression in Human Esophageal Adenocarcinoma Cells  Miral R. Sadaria,
Molecular Therapy - Nucleic Acids
SNARE-dependent glutamate release in megakaryocytes
Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines  Ronghua Zhao, MD, PhD, Luca.
Increased cerebral and renal endothelial nitric oxide synthase gene expression after cardiopulmonary bypass in the rat  C. David Mazer, MD, Francoise.
A first start for lung transplantation?
Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas  Fang Liu, Juxiang Cao, Jinxiang Wu, Kayleigh Sullivan, James Shen,
Stephen R. Broderick, MD, MPHS 
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Michael Lanuti, MD  The Journal of Thoracic and Cardiovascular Surgery 
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Keep it short and sweet  Ian A. Makey, MD, Scott B. Johnson, MD 
The future of cardiac surgery training: A survival guide
Spinal cord protection via alpha-2 agonist-mediated increase in glial cell-line–derived neurotrophic factor  Kirsten A. Freeman, MD, David A. Fullerton,
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Panagiotis Kougias, MD, Hong Chai, MD, PhD, Peter H. Lin, MD, Alan B
Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.
Presentation transcript:

Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A2  David Mauchley, MD, Xianzhong Meng, MD, PhD, Thomas Johnson, PhD, David A. Fullerton, MD, Michael J. Weyant, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 139, Issue 3, Pages 591-599 (March 2010) DOI: 10.1016/j.jtcvs.2009.10.061 Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Expression of group IIa secretory phospholipase A2(sPLA2) protein in esophageal adenocarcinoma cell lines. A, Immunofluorescence microscopy shows expression of group IIa secretory phospholipase A2(red) in esophageal adenocarcinoma cell lines FLO-1 and OE33. Nuclei are stained blue, and cell membranes are stained green. B, Reverse transcriptase polymerase chain reaction shows near equal expression of group IIa secretory phospholipase A2 in esophageal cancer cells. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; mRNA, messenger RNA; NS, not statistically significant. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 591-599DOI: (10.1016/j.jtcvs.2009.10.061) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Effect of group IIa secretory phospholipase A2 inhibition on esophageal adenocarcinoma cell number. Relative cell numbers after 72 hours of treatment of FLO-1 cells (A) and OE33 cells (B) relative to controls, as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Statistical significance relative to untreated controls and vehicle (dimethyl sulfoxide, DMSO) controls was reached with 10- and 20-μmol/L doses for FLO-1 cells and with 5-, 10-, and 20-μmol/L doses for OE33 cells. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 591-599DOI: (10.1016/j.jtcvs.2009.10.061) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Effect of group IIa secretory phospholipase A2 inhibition on esophageal adenocarcinoma cellular proliferation. Relative bromodeoxyuridine (BrdU) incorporation after 72 hours of treatment in FLO-1 cells (A) and OE33 cells (B) relative to controls. Statistical significance versus both untreated and vehicle (dimethyl sulfoxide, DMSO) controls was reached with 10- and 20-μmol/L doses in both cell types. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 591-599DOI: (10.1016/j.jtcvs.2009.10.061) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Infection of esophageal adenocarcinoma cells with lentiviral particles. Both FLO-1 and OE33 cells are efficiently infected with lentiviral particles derived from lentiviral expression vector pLVUT-tTR-KRAB (LVUT) and pLKO.1 puro constructs, as shown by green fluorescent protein expression under ultraviolet (UV) light (green). Infection with lentiviral particles did not affect cell shape or size. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 591-599DOI: (10.1016/j.jtcvs.2009.10.061) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Overexpression of group IIa secretory phospholipase A2(sPLA2) in esophageal adenocarcinoma cells augments cell growth. A, In quantitative reverse transcriptase polymerase chain reaction analysis of FLO-1 and OE33 cells infected with lentiviral expression vector pLVUT-tTR-KRAB (LVUT) with gene for secretory phospholipase A2, viral particles show significant overexpression of group IIa secretory phospholipase A2 relative to controls. B, Immunofluorescent microscopy of both FLO-1 and OE33 cells shows increased protein levels of group IIa secretory phospholipase A2(red) in cytoplasm of cells infected with viral particles derived from pLVUT-tTR-KRAB–secretory phospholipase A2 gene construct. C, Viable cell number is increased in both FLO-1 and OE33 cells that overexpress group IIa secretory phospholipase A2 relative to uninfected and pLVUT-tTR-KRAB–infected controls. D, FLO-1 and OE33 cells that overexpress group IIa secretory phospholipase A2 demonstrate greater cell proliferation than controls. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; UT, untreated; BrdU, bromodeoxyuridine. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 591-599DOI: (10.1016/j.jtcvs.2009.10.061) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 6 Genetic knockdown of group IIa secretory phospholipase A2(sPLA2) attenuates growth of esophageal adenocarcinoma cells. A, Quantitative reverse transcriptase polymerase chain reaction analysis of FLO-1 and OE33 cells infected with group IIa secretory phospholipase A2 short hairpin RNA (shRNA) viral particles shows significant reduction in expression relative to nontargeting (NT) and untreated (UT) controls. B, Immunofluorescent microscopy of both FLO-1 and OE33 cells shows decreased protein levels of group IIa secretory phospholipase A2(red) in cells infected with secretory phospholipase A2 short hairpin RNA viral particles relative to nontargeting short hairpin RNA control. C, Viable cell number is diminished in both FLO-1 and OE33 cells that have genetic knockdown of group IIa secretory phospholipase A2 transcript relative to uninfected and nontargeting controls. D, Knockdown of group IIa secretory phospholipase A2 expression results in attenuated cell proliferation relative to uninfected and nontargeting short hairpin RNA controls. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; BrdU, bromodeoxyuridine. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 591-599DOI: (10.1016/j.jtcvs.2009.10.061) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions